Bio logo

People  |   Products   |   Projection

Bio Integrates 2022 Agenda

LONDON, 17 MAY 2022
Leonardo Royal Hotel London Tower Bridge

KEYNOTES, FIRESIDE CHATS AND PANEL DISCUSSIONS

PLEASE NOTE The agenda and timings have not been finalised so maybe subject to change.

DELEGATES WILL BE FREE TO CHOOSE FROM TRACK 1, 2 or 3 AT ANY TIME.

Registration & Networking

08:00 – 08:50

Registration and networking

Welcome & Opening Remarks

08:50 – 09:00

Welcome & Opening Remarks

MARTINO PICARDO | Chairman | Discovery Park

Fireside Chat

09:00 – 09:20

Fireside Chat

An interview with: ANDREAS WALLNOEFER | Partner & Investor | Jeito Capital
Interviewed by: MARTINO PICARDO | Chairman | Discovery Park

Fireside Chat

09:20 – 09:40

Fireside Chat

An Interview with: Dr RUTH McKERNAN CBE | Neuroscientist, businesswoman and innovation leader
Interviewed by: TREVOR JONES CBE | Chairman and Board Member | e-Therapeutics, Respiratory Innovation Wales and Ascension Healthcare

PEOPLE

How do we assemble and accelerate our teams for success?

PRODUCTS

How do we protect, progress and pivot our products for maximal value?

PROJECTION

What does the future hold for life science investment, intellect and infrastructure?

Session 1

09:45 – 10:35

Living on the edge

With tech and biotech converging, how can we innovate and collaborate across the sector edges? Does innovation have to come from within, or can it come from CDMOs?

Making your product fit for purpose

How are you responding to the increasing interest, pressure, regulation, and legislation around the ethics, provenance, and sustainability of products? Are you ready? Can you see market opportunities?

 

Go big or go home

The Government’s Industrial Strategy and commitment to life science funding relies on companies scaling their science in the UK. How do you scale up in a fragmented ecosystem?

Networking

10:40 – 11:10

Networking Coffee

Session 2

11:15 – 12:05

The C word

The culture within an organisation can be its success or downfall. How do we build management teams and leadership structures to create an inspiring company culture?

Protect at all costs

The costs of protecting your IP can ramp up rapidly. How can you plan your IP strategy efficiently and cost-effectively?

Value in, value out

With a greater focus on accelerating development timelines, investors are expecting quicker returns. How can we accelerate products to deliver maximum value for patients and investors?

Session 3

12:10- 13:00

Get out(sourced)!

Finding the right outsourcing partners to help develop and scale your products is critical to milestones and budgets. How can we ensure we are working with the right partners at the right time?

Transfer targets

Tech transfer departments in Universities are inundated with potential translational science. How do they select the projects to back?

Networking

13:00 – 14:10

Networking Lunch

Session 4

14:10 – 15:00

Been there, done that

Success stories from those who have felt the fire at their feet, bridged the valley of death, scaled and sold their companies.

Preparing for the Next Pandemic

COVID-19 taught the life science industry a great deal. Now it’s time to capitalise on that knowledge. How can academia, SMEs and the government accelerate new solutions, overcome clinical, manufacturing, regulatory and commercialisation hurdles, and make sure we’re fully armed to tackle the next potential threat?

Session 5

15:05 – 15:55

Girls just wanna have fun(ds)

Less than 5% of investment goes to female-led businesses. What are we doing to address the gender investment gap? How can we apply this across other under-represented groups?

Fuelling the genetic medicine revolution

Nucleic acid (mRNA and DNA) vaccines aren’t necessarily new, but recent outcomes during the COVID pandemic are stimulating a renaissance in the wider biopharmaceutical industry as drug manufacturers turn their attention to issues such as speed-to-market, faster scale-up and, of course, safety.

Where you lead

Selecting your lead investors and assembling your syndicate is pivotal to the success of a biotech. Do you pick your investors, or do they pick you?

Closing

15:55 – 16:05

Closing remarks

MARTINO PICARDO | Chairman | Discovery Park

Networking

16:05 – 16:55

Drinks Reception

Registration and networking

08:00 – 08:50

Welcome & Opening Remarks

08:50 – 09:00

MARTINO PICARDO | Chairman | Discovery Park

Fireside Chat

09:00 – 09:20

ANDREAS WALLNOEFER | Partner | Jeito

Fireside Chat

09:20 – 09:40

Dr Ruth McKernan CBE | Neuroscientist, businesswoman and innovation leader

PEOPLE

How do we assemble and accelerate our teams for succes?

Session 1:

Living on the edge

09:45 – 10:35

With tech and biotech converging, how can we innovate and collaborate across the sector edges?

Networking

Coffee

10:40 – 11:10

Session 2:

The C word

11:15 – 12:05

The culture within an organisation can be its success or downfall. How do we build management teams and leadership structures to create an inspiring company culture?

Networking

Lunch

13:00 – 14:10

Session 5

Girls just wanna have fun(ds)

15:05 – 15:55

Less than 5% of investment goes to female-led businesses. What are we doing to address the gender investment gap? How can we apply this across other under-represented groups?

Closing Remarks

15:55 – 16:05

MARTINO PICARDO | Chairman | Discovery Park

 

Networking

Drinks Reception

16:05 – 16:55

PRODUCTS

How do we protect, progress and pivot our products for maximal value?

Session 1:

Making your product fit for purpose

09:45 – 10:35

How are you responding to the increasing interest, pressure, regulation, and legislation around the ethics, provenance, and sustainability of products? Are you ready? Can you see market opportunities?

Networking

Coffee

10:40 – 11:10

Session 2:

Protect at all costs

11:15 – 12:05

The costs of protecting your IP can ramp up rapidly. How can you plan your IP strategy efficiently and cost-effectively?

Session 3:

Get out(sourced)!

12:10- 13:00

Finding the right outsourcing partners to help develop and scale your products is critical to milestones and budgets. How can we ensure we are working with the right partners at the right time?

Networking

Lunch

13:00 – 14:10

Session 4:

Been there, done that

14:10 – 15:00

Success stories from those who have felt the fire at their feet, bridged the valley of death, scaled and sold their companies.

Session 5:

Fuelling the genetic medicine revolution

15:05 – 15:55

Nucleic acid (mRNA and DNA) vaccines aren’t necessarily new, but they’re driving a renaissance in the biopharmaceutical industry as drug manufacturers turn their attention to issues such as speed-to-market, faster scale-up and, of course, safety.

Closing Remarks

15:55 – 16:05

MARTINO PICARDO | Chairman | Discovery Park

Networking

Drinks Reception

16:05 – 16:55

PROJECTION

What does the future hold for life science investment, intellect and infrastructure?

Session 1:

Value in, value out

09:45 – 10:35

With a greater focus on accelerating development timelines, investors are expecting quicker returns. How can we accelerate products to deliver maximum value for patients and investors?

Networking

Coffee

10:40 – 11:10

Session 2:

Go big or go home

11:15 – 12:05

The Government’s Industrial Strategy and commitment to life science funding relies on companies scaling their science in the UK. How do you scale for success?

Session 3:

Transfer targets

12:10- 13:00

Tech transfer departments in Universities are inundated with potential translational science. How do they select the projects to back?

Networking

Lunch

13:00 – 14:10

Session 4:

Preparing for the Next Pandemic

14:10 – 15:00

COVID-19 taught the life science industry a great deal. Now it’s time to capitalise on that knowledge. How can academia, SMEs and the government accelerate new solutions, overcome clinical, manufacturing, regulatory and commercialisation hurdles, and make sure we’re fully armed to tackle the next potential threat?

Session 5

Where you lead

15:05 – 15:55

Selecting your lead investors and assembling your syndicate is pivotal to the success of a biotech. Do you pick your investors, or do they pick you?

Closing Remarks

15:55 – 16:05

MARTINO PICARDO | Chairman | Discovery Park

Networking

Drinks Reception

16:05 – 16:55

Sign up for life science integrates news

Get the latest news and updates by signing up today.

By signing up to the life science integrates newsletter, you have read and agree to our Privacy Policy, including our Cookie use.

Bio logo

People  |   Products   |   Projection